Nephrocare Health Services share price
NSE: NEPHROPLUSBSE: 544647Healthcare ServicesSmall Cap
Last close ₹596.45down ₹5.95 (0.99%)BSE ₹597.30
Share price at the NSE close on 23 Oct 2026. Previous close ₹602.40.
Range of traded prices from listing on 17 Dec 2025 to 23 Oct 2026
₹446.00Low, 19 Dec 2025₹781.50High, 11 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹5,998 Cr739th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 5.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,48,08043.1% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 11 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹282 Crup 6.08%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹32 Crup 5.28%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 11.3%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Dec 2025Filed 10 Feb | Mar 2026Filed 19 May | Jun 2026Filed 11 Aug |
|---|---|---|---|
| Revenue | 260 | 266 | 282 |
| Net profit | 32 | 30 | 32 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 12.4% | 11.4% | 11.3% |
Consolidated. The 3 quarters from Dec 2025, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Healthcare services, which carries all its revenue.
Mutual funds holding it
26 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 3 of the 7 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.Mutual fund holdings
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 12
- Bought againBought again. Funds that held it at the month's end, had not held it the month before, and held it in an earlier month.
- 1
- AddedAdded. Funds that held more shares than at the end of the month before.
- 6
- CutCut. Funds that held fewer shares than at the end of the month before.
- 1
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 6
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end.
- 1
| Fund | |||
|---|---|---|---|
 SBI Healthcare Opportunities FundSBI Mutual Fund | 10,00,000 | 1.12% | ₹66.0 Cr |
 DSP Healthcare FundDSP Mutual Fund | 6,34,983 | 1.12% | ₹41.9 Cr |
 Helios Small Cap FundHelios Mutual Fund | 3,81,334 | 1.33% | ₹25.2 Cr |
 Bandhan Innovation FundBandhan Mutual Fund | 3,64,005 | 0.78% | ₹24.0 Cr |
 LIC Mf Infrastructure FundLIC Mutual Fund | 3,52,000 | 2.01% | ₹23.2 Cr |
| Bandhan Small Cap FundBandhan Mutual Fund | 2,81,637 | 0.05% | ₹18.6 Cr |
| LIC Mf Multi Asset Allocation FundLIC Mutual Fund | 2,01,000 | 1.37% | ₹13.3 Cr |
 ICICI Prudential Retirement Fund - Hybrid AggressiveICICI Prudential Mutual Fund | 1,89,672 | 0.99% | ₹12.5 Cr |
| LIC Mf Value FundLIC Mutual Fund | 1,60,000 | 3.14% | ₹10.6 Cr |
| Bandhan Contra FundBandhan Mutual Fund | 1,23,565 | 0.48% | ₹8.15 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Peers and competitors
Healthcare Service Provider, 36 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Nephrocare Health Services in market cap.
Nephrocare Health Services is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Dr. Lal Path LabsLALPATHLAB | 30,854 | 56.9 | 12.3 | 35.7 | +14.3% | +5.6% | 23.2% | 26.2% | 0.87% |
 Vijaya Diagnostic CentreVIJAYA | 14,311 | 76.3 | 15.0 | 39.4 | +20.2% | +24.9% | 21.4% | 27.8% | 0.14% |
 Metropolis HealthcareMETROPOLIS | 10,849 | 53.8 | 7.2 | 25.6 | +21.8% | +32.6% | 14.2% | 18.6% | 0.38% |
 Thyrocare TechnologiesTHYROCARE | 7,372 | 41.8 | 12.6 | 25.9 | +21.1% | +65.7% | 31.1% | 37.9% | 2.02% |
 Krsnaa DiagnosticsKRSNAA | 1,617 | 16.6 | 1.6 | 8.2 | +10.2% | +21.5% | 10.5% | 8.0% | 0.40% |
 Suraksha DiagnosticSURAKSHA | 1,559 | 43.6 | 6.4 | 15.0 | +23.3% | +8.1% | 15.7% | 24.0% | 0.17% |
 3B Blackbio Dx3BBLACKBIO | 1,145 | 20.6 | 3.5 | 19.6 | +54.3% | +13.2% | 18.7% | 14.1% | 0.37% |
 Health X PlatformHEALTHX | 849 | – | 1.3 | – | +28.8% | – | −3.1% | −9.4% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
21 Oct · Analysts
Sep 2026
22 Sep · Analysts
18 Sep · Rating
Nephrocare Health Services share price by year
Each calendar year to 2025.Nephrocare Health Services share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 468.70 | – | 476.20 | 449.15 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 17 Dec 2025.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 604.00 | 604.00 | 580.20 | 596.45 | 591.29 | 1,48,080 | 43.1% |
| 22 Oct 2026 | 602.00 | 607.25 | 595.00 | 602.40 | 601.77 | 1,22,221 | 45.8% |
| 21 Oct 2026 | 607.00 | 615.20 | 602.80 | 608.90 | 608.75 | 1,08,595 | 54.2% |
| 19 Oct 2026 | 612.00 | 618.80 | 603.60 | 611.55 | 609.86 | 1,52,507 | 56.0% |
| 16 Oct 2026 | 611.65 | 619.40 | 609.25 | 614.35 | 615.18 | 1,35,447 | 59.2% |
| 15 Oct 2026 | 619.00 | 622.65 | 609.00 | 611.65 | 614.99 | 1,61,338 | 55.3% |
| 14 Oct 2026 | 621.50 | 623.45 | 608.40 | 617.15 | 615.77 | 1,34,499 | 52.2% |
| 13 Oct 2026 | 608.10 | 624.20 | 601.05 | 620.95 | 612.84 | 2,51,850 | 53.2% |
| 12 Oct 2026 | 616.40 | 630.35 | 612.30 | 619.55 | 622.04 | 2,03,254 | 47.3% |
| 9 Oct 2026 | 629.80 | 631.15 | 608.00 | 616.40 | 615.53 | 2,29,573 | 61.0% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Nephrocare Health Services Limited
- NSE symbol
- NEPHROPLUS
- BSE code
- 544647
- ISIN
- INE428V01029
- Industry
- Healthcare Services
- Listed
- Dec 2025
- Face value
- ₹2
- CIN
- L85100TG2009PLC066359
- Corporate identity number, the registrar of companies' code for it